Figure 1. Mortality among Patients with Colorectal Cancer, According to Regular Use or Nonuse of Aspirin after Diagnosis and PIK3CA Mutation Status.
Panels A and B show colorectal cancer–specific mortality among patients with mutant-PIK3CA tumors and those with wild-type PIK3CA tumors, respectively, and Panels C and D show overall mortality in the respective subgroups of patients.